Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patients

Full text
Author(s):
Show less -
Costa, Andre L. F. [1] ; Santos, Bruna A. [2] ; Torregrossa, Vinicius R. [2] ; Miranda, Eliana C. M. [2] ; Vigorito, Afonso C. [2] ; Palmieri, Michelle [3] ; Ricardo, Ana L. F. [1] ; Sarmento, Dmitry J. S. [3, 4] ; Mamana, Ana C. [5] ; Tozetto-Mendoza, Tania R. [5] ; Correa, M. Elvira P. [2] ; Braz-Silva, Paulo H. [3, 5]
Total Authors: 12
Affiliation:
[1] Cruzeiro Do Sul Univ UNICSUL, Postgrad Program Dent, Sao Paulo - Brazil
[2] Univ Campinas UNICAMP, Hematol & Hemotherapy Ctr, Rua Carlos Chagas 480, Campinas, SP - Brazil
[3] Univ Sao Paulo, Sch Dent, Dept Stomatol, Sao Paulo - Brazil
[4] State Univ Paraiba, Sch Dent, Dept Stomatol, Araruna - Brazil
[5] Univ Sao Paulo, Sch Med, Inst Trop Med Sao Paulo, Lab Virol LIM52, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: ORAL DISEASES; v. 27, n. 6, p. 1572-1579, SEP 2021.
Web of Science Citations: 0
Abstract

Objectives To evaluate the oral shedding of herpesviruses in patients undergoing hematopoietic stem cell transplantation (HSCT) and correlate it with oral mucositis (OM). Methods Saliva samples were collected before the HSCT and on day D + 8. Multiplex Polymerse Chain Reaction (PCR) was performed to detect herpes simplex virus (HSV)-1 and HSV-2, Epstein-Barr virus (EBV), Cytomegalovirus (CMV), Variella-zoster virus (VZV), and human herpesvirus (HHV)-6, HHV-7, and HHV-8. OM was assessed according to WHO criteria. Results Thirty one patients were enrolled, in which 20 of 31 (64.5%) were males; median age was 50 (21-70) years; 16 of 31 (51.6%) underwent allo-HSCT; and 15 of 31 (48.4%) underwent auto-HSCT. On D + 8, OM grades III and IV were observed in 8 of 31 (25.8%) patients. In the first salivary collection, EBV was found in 24 of 31 (77.4%), followed by HHV-6 (7/31, 22.6%) and HHV-7 (8/31 25.8%). In the second collection, EBV was found in 24 of 27(89%), followed by HSV-1 (8/27, 30%) and CMV, HHV-6, and HHV-7 (5/27, 18.5%, each one). On D + 8, OM grades II and IV were associated with the presence of HSV-1. HSV-1 was also associated with worsening degrees of OM on D + 15. Conclusion The presence of HSV-1 and CMV in oral samples was more frequent on day D + 8 after HSCT. HSV-1 detection was associated with severity and worsening of OM. HSV-1 and CMV seem to be associated with oral dysbiosis due to HSCT. (AU)

FAPESP's process: 15/07727-9 - Evaluation of immunoregulatory microenvironment of oral premalignant lesions, squamous cell carcinomas and oropharyngeal carcinomas related to HPV or not.
Grantee:Paulo Henrique Braz da Silva
Support Opportunities: Regular Research Grants